Other results Pokaż wszystkie wyniki (4)

Search results for: CAPECITABINE

• Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms

  Publication

  • E. Chatzellis
  • A. Angelousi
  • K. Daskalakis
  • M. Tsoli
  • K. Alexandraki
  • E. Wachuła
  • A. Meirovitz
  • O. Maimon
  • S. Grozinsky-Glasberg
  • D. Gross... and 3 others

  - NEUROENDOCRINOLOGY - Year 2019

  Full text to download in external service

• Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms”

  Publication

  • E. Chatzellis
  • K. Daskalakis
  • A. Angelousi
  • M. Tsoli
  • K. Alexandraki
  • E. Wachula
  • A. Meirovitz
  • O. Maimon
  • S. Grozinsky-Glasberg
  • D. Gross... and 3 others

  - NEUROENDOCRINOLOGY - Year 2020

  Full text to download in external service

• Capecitabine and temozolomide combination for treatment of high-grade, well-differentiated neuroendocrine tumour and poorly-differentiated neuroendocrine carcinoma — retrospective analysis

  Publication

  • W. Rogowski
  • E. Wachuła
  • A. Gorzelak
  • A. Lebiedzińska
  • V. Sulżyc-Bielicka
  • E. Iżycka-Świeszewska
  • J. Żołnierek
  • B. Kos-Kudła

  - Endokrynologia Polska (Polish Journal of Endocrinology) - Year 2019

  Full text to download in external service

• Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?

  Publication

  • K. Kaźmierczak-Siedlecka
  • N. Bulman
  • P. Ulasiński
  • B. K. Sobocki
  • K. Polom
  • L. Marano
  • L. Kalinowski
  • K. Skonieczna-Żydecka

  - Gut Microbes - Year 2023

  Intestinal bacteria are equipped with an enzyme apparatus that is involved in the active biotrans-formation of xenobiotics, including drugs. Pharmacomicrobiomics, a new area of pharmacology, analyses interactions between bacteria and xenobiotics. However, there is another side to the coin. Pharmacotherapeutic agents can significantly modify the microbiota, which consequently affects their efficacy. In this review, we comprehensively...

  Full text available to download